Patents by Inventor Eiji IDEUE

Eiji IDEUE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLOALKYLUREA DERIVATIVE
    Publication number: 20250066342
    Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.
    Type: Application
    Filed: October 25, 2024
    Publication date: February 27, 2025
    Inventors: Eiji IDEUE, Masafumi KOMIYA, Shoukou LEE, Shunichiro UESUGI, Yuta FUNAKOSHI
  • Cycloalkylurea derivative
    Patent number: 12162872
    Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.
    Type: Grant
    Filed: November 26, 2020
    Date of Patent: December 10, 2024
    Assignee: Sumitomo Pharma Co., Ltd.
    Inventors: Eiji Ideue, Masafumi Komiya, Shoukou Lee, Shunichiro Uesugi, Yuta Funakoshi
  • PHENYL UREA DERIVATIVE
    Publication number: 20240308960
    Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin receptor type 2, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing a disease such as narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome.
    Type: Application
    Filed: May 26, 2022
    Publication date: September 19, 2024
    Inventors: Masafumi KOMIYA, Shunichiro UESUGI, Eiji IDEUE, Shoukou LEE, Daisuke TANAKA, Yuta FUNAKOSHI
  • CYCLOALKYLUREA DERIVATIVE
    Publication number: 20230088694
    Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.
    Type: Application
    Filed: November 26, 2020
    Publication date: March 23, 2023
    Applicant: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Eiji IDEUE, Masafumi KOMIYA, Shoukou LEE, Shunichiro UESUGI, Yuta FUNAKOSHI
  • Cycloalkylurea derivative
    Patent number: 11352357
    Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: June 7, 2022
    Assignee: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Eiji Ideue, Masafumi Komiya, Shoukou Lee, Shunichiro Uesugi, Yuta Funakoshi
  • CYCLOALKYLUREA DERIVATIVE
    Publication number: 20220081441
    Abstract: The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc.
    Type: Application
    Filed: November 15, 2021
    Publication date: March 17, 2022
    Applicant: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Eiji IDEUE, Masafumi KOMIYA, Shoukou LEE, Shunichiro UESUGI, Yuta FUNAKOSHI
  • Substituted purine derivative
    Patent number: 10703755
    Abstract: The present invention relates to a substituted purine derivative of formula (1) wherein R1 is alkoxy or the like, R2 is alkyl or the like, Ring Q1 is aryl or the like, W1 is alkylene or the like, Ring Q2 is aromatic carbocyclyl or the like, n is 1-4, R3 is hydrogen atom or the like, X1 is single bond or the like, W2 is alkylene or the like, and R4 is hydrogen atom or the like, or a pharmaceutically acceptable salt thereof, which has a potent inhibitory effect against TLR7, and thereby is useful for treating autoimmune disease.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: July 7, 2020
    Assignee: SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Shingo Tojo, Yoshiaki Isobe, Eiji Ideue, Hiroaki Fujiwara, Daisuke Urabe
  • SUBSTITUTED PURINE DERIVATIVE
    Publication number: 20190169191
    Abstract: The present invention relates to a substituted purine derivative of formula (1) wherein R1 is alkoxy or the like, R2 is alkyl or the like, Ring Q1 is aryl or the like, W1 is alkylene or the like, Ring Q2 is aromatic carbocyclyl or the like, n is 1-4, R3 is hydrogen atom or the like, X1 is single bond or the like, W2 is alkylene or the like, and R4 is hydrogen atom or the like, or a pharmaceutically acceptable salt thereof, which has a potent inhibitory effect against TLR7, and thereby is useful for treating autoimmune disease.
    Type: Application
    Filed: April 25, 2017
    Publication date: June 6, 2019
    Applicant: SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Shingo TOJO, Yoshiaki ISOBE, Eiji IDEUE, Hiroaki FUJIWARA, Daisuke URABE